Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Matsue Y"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 26
Tytuł:
Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights from REALITY-AHF.
Autorzy:
Xanthopoulos A; Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Bourazana A; Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Matsue Y; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-0033, Japan.
Fujimoto Y; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-0033, Japan.
Oishi S; Department of Cardiology, Himeji Cardiovascular Center, Himeji 670-8560, Japan.
Akiyama E; Division of Cardiology, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Suzuki S; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima 960-1295, Japan.
Yamamoto M; Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8577, Japan.
Kida K; Department of Pharmacology, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Okumura T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Giamouzis G; Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Skoularigis J; Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Triposkiadis F; Department of Cardiology, University Hospital of Larissa, 41110 Larissa, Greece.
Kitai T; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan.; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka 564-8565, Japan.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2023 May 28; Vol. 12 (11). Date of Electronic Publication: 2023 May 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction.
Autorzy:
Ito M; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.
Maeda D; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan. .; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan. .
Shiraishi Y; Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Dotare T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.
Sunayama T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.
Nogi K; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
Takei M; Department of Cardiology, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Ueda T; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
Nogi M; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
Ishihara S; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
Nakada Y; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.
Kawakami R; Department of Cardiology, Saiseikai Suita Hospital, Suita, Japan.
Kagiyama N; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.
Kitai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Oishi S; Department of Cardiology, Himeji Cardiovascular Center, Himeji, Japan.
Akiyama E; Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Suzuki S; Department of Cardiology and Hematology, Fukushima Medical University, Fukushima, Japan.
Yamamoto M; Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Kida K; Department of Pharmacology, St. Marianna University School of Medicine, Kanagawa, Japan.
Okumura T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nagatomo Y; Department of Cardiology, National Defense Medical College, Tokorozawa, Japan.
Kohno T; Department of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Nakano S; Department of Cardiology, International Medical Center, Saitama Medical University, Saitama, Japan.
Kohsaka S; Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Yoshikawa T; Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan.
Saito Y; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Japan.; Nara Prefectural Hospital Organization, Nara Prefecture Seiwa Medical Center, Nara, Japan.
Minamino T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 3-1-3 Hongo, Bunkyo-ku, Tokyo, Japan.; Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Oct 05; Vol. 12 (1), pp. 16611. Date of Electronic Publication: 2022 Oct 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure*/drug therapy
Ventricular Dysfunction, Left*/drug therapy
Aftercare ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Hospitalization ; Humans ; Patient Discharge ; Prognosis ; Receptors, Mineralocorticoid ; Retrospective Studies ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors.
Autorzy:
Higaki A; Department of Cardiology, Ehime Prefectural Central Hospital, Matsuyama, Japan. .
Okayama H; Department of Cardiology, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Homma Y; Department of Infectious Diseases, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Sano T; Department of Cardiovascular Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.
Kitai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.; Department of Rehabilitation, Kobe City Medical Center General Hospital, Kobe, Japan.
Yonetsu T; Department of Interventional Cardiology, Tokyo Medical and Dental University, Tokyo, Japan.
Torii S; Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Kohsaka S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Kuroda S; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Node K; Department of Cardiovascular Medicine, Saga University, Saga, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Matsumoto S; Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Aug 10; Vol. 12 (1), pp. 13606. Date of Electronic Publication: 2022 Aug 10.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*/complications
Cardiovascular Diseases*
Hospital Mortality ; Humans ; Lymphocytes ; Neutrophils ; Prognosis ; ROC Curve ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical significance of I-BMIPP washout rate in patients with uncertain chronic heart failure.
Autorzy:
Aoshima C; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Fujimoto S; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan. .
Kudo A; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Kawaguchi YO; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Takamura K; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Kato T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Kawamura Y; Department of Radiological Technology, Juntendo University Hospital, Tokyo, Japan.
Kimura S; Department of Radiological Technology, Juntendo University Hospital, Tokyo, Japan.
Kamo Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Nozaki YO; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Takahashi D; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Tomizawa N; Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hiki M; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Kasai T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Nojiri S; Juntendo University Medical Technology Innovation Center, Tokyo, Japan.
Miyauchi H; Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Hirano KI; Laboratory of Cardiovascular Disease, Novel, Non-Invasive, and Nutritional Therapeutics and Triglyceride Research Center (TGRC), Department of Triglyceride Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
Shimada K; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.
Murakami K; Department of Radiology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Minamino T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo Bunkyo-ku, Tokyo, 113-8421, Japan.; Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo, Japan.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Jul; Vol. 49 (9), pp. 3129-3139. Date of Electronic Publication: 2022 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Failure*/diagnostic imaging
Iodobenzenes*
Chronic Disease ; Fatty Acids ; Heart ; Humans ; Iodine Radioisotopes ; Tomography, Emission-Computed, Single-Photon/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prognostic value of postural hypotension in hospitalized patients with heart failure.
Autorzy:
Sunayama T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Maeda D; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.; Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. .; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. .
Kagiyama N; Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.; Department of Digital Health and Telemedicine R&D, Juntendo University, Tokyo, Japan.; Department of Cardiovascular Biology and Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Jujo K; Department of Cardiology, Nishiarai Heart Center Hospital, Tokyo, Japan.
Saito K; Department of Rehabilitation, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Kamiya K; Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
Saito H; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.; Department of Rehabilitation, Kameda Medical Center, Kamogawa, Japan.
Ogasawara Y; Department of Nursing, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Maekawa E; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Konishi M; Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Kitai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.; Department of Rehabilitation, Kobe City Medical Center General Hospital, Kobe, Japan.
Iwata K; Department of Rehabilitation, Kobe City Medical Center General Hospital, Kobe, Japan.
Wada H; Department of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Hiki M; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Dotare T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Kasai T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nagamatsu H; Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Ozawa T; Department of Rehabilitation, Odawara Municipal Hospital, Odawara, Japan.
Izawa K; Department of Rehabilitation, Kasukabe Chuo General Hospital, Kasukabe, Japan.
Yamamoto S; Department of Rehabilitation, Shinshu University Hospital, Matsumoto, Japan.
Aizawa N; Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Okinawa, Japan.
Yonezawa R; Rehabilitation Center, Kitasato University Medical Center, Kitamoto, Japan.
Oka K; Department of Rehabilitation, Saitama Citizens Medical Center, Saitama, Japan.
Momomura SI; Saitama Citizens Medical Center, Saitama, Japan.
Minamino T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.; Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Feb 18; Vol. 12 (1), pp. 2802. Date of Electronic Publication: 2022 Feb 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prognosis*
Heart Failure/*diagnosis
Hypertension/*diagnosis
Hypotension, Orthostatic/*diagnosis
Aged ; Aged, 80 and over ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Blood Pressure/physiology ; Female ; Heart Failure/complications ; Heart Failure/mortality ; Heart Failure/pathology ; Hospitalization ; Humans ; Hypertension/complications ; Hypertension/mortality ; Hypertension/pathology ; Hypotension, Orthostatic/complications ; Hypotension, Orthostatic/mortality ; Hypotension, Orthostatic/pathology ; Logistic Models ; Male ; Predictive Value of Tests ; Supine Position/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure.
Autorzy:
Yoshioka K; Department of Cardiology, Kameda Medical Center, Chiba, Japan.; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Maeda D; Department of Cardiovascular Medicine, Juntendo University, Tokyo, Japan.; Department of Cardiology, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Okumura T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kida K; Department of Pharmacology, St. Marianna University School of Medicine, Kawasaki, Japan.
Oishi S; Department of Cardiology, Himeji Cardiovascular Center, Hyogo, Japan.
Akiyama E; Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Suzuki S; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yamamoto M; Cardiovascular Division, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Mizukami A; Department of Cardiology, Kameda Medical Center, Chiba, Japan.
Kuroda S; Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA.
Kagiyama N; Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.; Department of Cardiovascular Biology and Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.; Department of Digital Health and Telemedicine R&D, Juntendo University, Tokyo, Japan.
Yamaguchi T; Department of Cardiology, Cardiovascular Center, Toranomon Hospital, Tokyo, Japan.
Sasano T; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Matsumura A; Department of Cardiology, Kameda Medical Center, Chiba, Japan.
Kitai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.
Matsue Y; Department of Cardiovascular Medicine, Juntendo University, Tokyo, Japan. .; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Feb 08; Vol. 12 (1), pp. 2127. Date of Electronic Publication: 2022 Feb 08.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Registries*
Diuretics/*administration & dosage
Furosemide/*administration & dosage
Heart Failure/*drug therapy
Administration, Intravenous ; Aged ; Aged, 80 and over ; Female ; Heart Failure/mortality ; Humans ; Japan/epidemiology ; Male ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Worsening renal function in acute heart failure in the context of diuretic response.
Autorzy:
Emmens JE; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Ter Maaten JM; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Figarska SM; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Sama IE; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Cotter G; Momentum Research and Inserm U942 MASCOT, Paris, France.
Cleland JGF; Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Well-Being, University of Glasgow, Glasgow Royal Infirmary, Glasgow, UK.; National Heart & Lung Institute, Imperial College, London, UK.
Davison BA; Momentum Research and Inserm U942 MASCOT, Paris, France.
Felker GM; Division of Cardiology, Department of Medicine, Duke University, Durham, NC, USA.; Duke Clinical Research Institute, Durham, NC, USA.
Givertz MM; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.
Greenberg B; University of California San Diego Health, Sulpizio Cardiovascular Institute, La Jolla, CA, USA.
Pang PS; Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Severin T; Novartis Pharma, Basel, Switzerland.
Gimpelewicz C; Novartis Pharma, Basel, Switzerland.
Metra M; Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
Voors AA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Teerlink JR; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California, San Francisco, CA, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Feb; Vol. 24 (2), pp. 365-374. Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Diuretics*/therapeutic use
Heart Failure*
Acute Disease ; Humans ; Kidney/physiology ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients.
Autorzy:
Kitakata H; Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Kohsaka S; Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Kuroda S; Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195, USA.
Nomura A; Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8641, Japan.
Kitai T; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan.
Yonetsu T; Department of Interventional Cardiology, Tokyo Medical and Dental University, Tokyo 113-8513, Japan.
Torii S; Department of Cardiology, Tokai University School of Medicine, Isehara 259-1193, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Matsumoto S; Department of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo 143-8540, Japan.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 Jul 13; Vol. 10 (14). Date of Electronic Publication: 2021 Jul 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure.
Autorzy:
Maeda D; Department of Cardiology, Osaka Medical College, Takatsuki, Japan.
Kagiyama N; Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.; Department of Digital Health and Telemedicine R&D, Juntendo University, Tokyo, Japan.; Department of Cardiovascular Biology and Medicine, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Jujo K; Department of Cardiology, Nishiarai Heart Center Hospital, Tokyo, Japan.
Saito K; Department of Rehabilitation, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Kamiya K; Department of Rehabilitation, School of Allied Health Sciences, Kitasato University, Sagamihara, Japan.
Saito H; Department of Rehabilitation, Kameda Medical Center, Kamogawa, Japan.; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ogasahara Y; Department of Nursing, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Maekawa E; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Konishi M; Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Kitai T; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Iwata K; Department of Rehabilitation, Kobe City Medical Center General Hospital, Kobe, Japan.
Wada H; Department of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Hiki M; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Dotare T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sunayama T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kasai T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nagamatsu H; Department of Cardiology, Tokai University School of Medicine, Isehara, Japan.
Ozawa T; Department of Rehabilitation, Odawara Municipal Hospital, Odawara, Japan.
Izawa K; Department of Rehabilitation, Kasukabe Chuo General Hospital, Kasukabe, Japan.
Yamamoto S; Department of Rehabilitation, Shinshu University Hospital, Matsumoto, Japan.
Aizawa N; Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Okinawa, Japan.
Yonezawa R; Rehabilitation Center, Kitasato University Medical Center, Kitamoto, Japan.
Oka K; Department of Rehabilitation, Saitama Citizens Medical Center, Saitama, Japan.
Momomura SI; Saitama Citizens Medical Center, Saitama, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. .; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jun 07; Vol. 11 (1), pp. 11957. Date of Electronic Publication: 2021 Jun 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alanine Transaminase/*metabolism
Aspartate Aminotransferases/*metabolism
Biomarkers/*metabolism
Frailty/*complications
Heart Failure/*enzymology
Aged ; Aged, 80 and over ; Cause of Death ; Cohort Studies ; Female ; Heart Failure/complications ; Heart Failure/mortality ; Hospitalization/statistics & numerical data ; Humans ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Prognosis ; Proportional Hazards Models ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.
Autorzy:
Hiki M; Department of Emergency Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.; Department of Cardiovascular Biology and Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Tabe Y; Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Ai T; Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Harada N; Department of Respiratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Sugimoto K; Department of Coloproctological Surgery, Juntendo University Faculty of Medicine, Tokyo, Japan.
Matsushita Y; Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Matsushita M; Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Wakita M; Department of Clinical Laboratory, Juntendo University Hospital, Juntendo University Faculty of Medicine, Tokyo, Japan.
Misawa S; Department of Clinical Laboratory, Juntendo University Hospital, Juntendo University Faculty of Medicine, Tokyo, Japan.
Idei M; Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.; Medical Technology Innovation Center, Juntendo University Faculty of Medicine, Tokyo, Japan.
Miida T; Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Tamura N; Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine, Tokyo, Japan.
Takahashi K; Department of Respiratory Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Naito T; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Apr 06; Vol. 16 (4), pp. e0249449. Date of Electronic Publication: 2021 Apr 06 (Print Publication: 2021).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/blood
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19 Serological Testing*
Antibodies, Viral/*blood
Immunoglobulin G/*blood
Immunoglobulin M/*blood
SARS-CoV-2/*metabolism
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Immunoassay ; Japan/epidemiology ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Worsening renal function during intensive blood pressure control: another example of not prognostically relevant creatinine rise?
Autorzy:
Ito M; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Minamino T; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development, Tokyo, Japan.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Mar; Vol. 23 (3), pp. 393-395. Date of Electronic Publication: 2020 Oct 02.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Heart Failure*
Blood Pressure ; Creatinine ; Glomerular Filtration Rate ; Humans ; Kidney
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.
Autorzy:
Bozkurt B
Coats AJS
Tsutsui H
Abdelhamid CM
Adamopoulos S
Albert N
Anker SD
Atherton J
Böhm M
Butler J
Drazner MH
Michael Felker G
Filippatos G
Fiuzat M
Fonarow GC
Gomez-Mesa JE
Heidenreich P
Imamura T
Jankowska EA
Januzzi J
Khazanie P
Kinugawa K
Lam CSP
Matsue Y
Metra M
Ohtani T
Francesco Piepoli M
Ponikowski P
Rosano GMC
Sakata Y
Seferović P
Starling RC
Teerlink JR
Vardeny O
Yamamoto K
Yancy C
Zhang J
Zieroth S
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Mar; Vol. 23 (3), pp. 352-380. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiology*
Heart Failure*
Australia ; Canada ; China ; Humans ; India ; Japan ; New Zealand ; Prognosis ; Stroke Volume ; Ventricular Function, Left ; Writing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study.
Autorzy:
Matsue Y; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kamiya K; Department of Rehabilitation, School of Allied Health Science, Kitasato University, Tokyo, Japan.
Saito H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Department of Rehabilitation, Kameda Medical Center, Kamogawa, Japan.
Saito K; Department of Rehabilitation, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Ogasahara Y; Department of Nursing, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Maekawa E; Department of Cardiovascular Medicine, Kitasato University School of Medicine, Tokyo, Japan.
Konishi M; Division of Cardiology, Yokohama City University Medical Center, Yokohama, Japan.
Kitai T; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Iwata K; Department of Rehabilitation, Kobe City Medical Center General Hospital, Kobe, Japan.
Jujo K; Department of Cardiology, Nishiarai Heart Center Hospital, Tokyo, Japan.
Wada H; Department of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Shimotsuke, Japan.
Kasai T; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nagamatsu H; Department of Cardiology, Tokai University School of Medicine, Tokyo, Japan.
Ozawa T; Department of Rehabilitation, Odawara Municipal Hospital, Odawara, Japan.
Izawa K; Department of Rehabilitation, Kasukabe Chuo General Hospital, Kasukabe, Japan.
Yamamoto S; Department of Rehabilitation, Shinshu University Hospital, Matsumoto, Japan.
Aizawa N; Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Nishihara, Japan.
Yonezawa R; Department of Rehabilitation, Kitasato University Medical Center, Kitasato, Japan.
Oka K; Department of Rehabilitation, Saitama Citizens Medical Center, Saitama, Japan.
Momomura SI; Department of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University, Shimotsuke, Japan.
Kagiyama N; Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.; West Virginia University Heart and Vascular Institute, Morgantown, WV, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Nov; Vol. 22 (11), pp. 2112-2119. Date of Electronic Publication: 2020 Jul 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Frailty*/physiopathology
Heart Failure*/physiopathology
Age Factors ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Frail Elderly ; Humans ; Male ; Prevalence ; Prognosis ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Derivation and Validation of Clinical Prediction Models for Rapid Risk Stratification for Time-Sensitive Management for Acute Heart Failure.
Autorzy:
Shiraishi Y; Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Kohsaka S; Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Abe T; Biostatistics, Clinical and Translational Research Center, Keio University School of Medicine, Tokyo 160-8582, Japan.; School of Data Science, Yokohama City University, Yokohama 236-0027, Japan.
Nagai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka 565-8565, Japan.; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine Hokkaido University, Sapporo 060-8638, Japan.
Goda A; Department of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo 181-8611, Japan.
Nishihata Y; Department of Cardiology, St. Luke's International Hospital, Tokyo 104-8560, Japan.
Nagatomo Y; Department of Cardiology, National Defense Medical College Hospital, Tokorozawa 359-8513, Japan.
Saji M; Department of Cardiology, Sakakibara Heart Institute, Tokyo 183-0003, Japan.
Toyosaki Y; Department of Cardiology, Saitama Medical University International Medical Center, Saitama 350-1298, Japan.
Takei M; Department of Cardiology, Tokyo Saiseikai Central Hospital, Tokyo 108-0073, Japan.
Kitai T; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe 650-0047, Japan.
Kohno T; Department of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo 181-8611, Japan.
Fukuda K; Department of Cardiology, Keio University School of Medicine, Tokyo 160-8582, Japan.
Matsue Y; Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Anzai T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka 565-8565, Japan.; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine Hokkaido University, Sapporo 060-8638, Japan.
Yoshikawa T; Department of Cardiology, Sakakibara Heart Institute, Tokyo 183-0003, Japan.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Oct 23; Vol. 9 (11). Date of Electronic Publication: 2020 Oct 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure.
Autorzy:
Yoshioka K; Department of Cardiology, Kameda Medical Center, Chiba, Japan.; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Matsue Y; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Okumura T; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kida K; Department of Pharmacology, St. Marianna University School of Medicine, Kawasaki, Japan.
Oishi S; Department of Cardiology, Himeji Cardiovascular Center, Hyogo, Japan.
Akiyama E; Division of Cardiology, Yokohama City University Medical Center, Kanagawa, Japan.
Suzuki S; Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yamamoto M; Cardiovascular Division, Institute of Clinical Medicine, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.
Mizukami A; Department of Cardiology, Kameda Medical Center, Chiba, Japan.
Kuroda S; Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States of America.
Kagiyama N; Department of Cardiology, The Sakakibara Heart Institute of Okayama, Okayama, Japan.
Yamaguchi T; Department of Cardiology, Cardiovascular Center, Toranomon Hospital, Tokyo, Japan.
Sasano T; Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Matsumura A; Department of Cardiology, Kameda Medical Center, Chiba, Japan.
Kitai T; Department of Cardiovascular Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Jun 26; Vol. 15 (6), pp. e0235493. Date of Electronic Publication: 2020 Jun 26 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Heart Failure/*physiopathology
Kidney/*physiopathology
Natriuretic Peptide, Brain/*metabolism
Acute Disease ; Aged ; Aged, 80 and over ; Female ; Heart Failure/diagnosis ; Heart Failure/metabolism ; Humans ; Male ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of the Geriatric Nutritional Risk Index on In-Hospital Mortality and Length of Hospitalization in Patients with Acute Decompensated Heart Failure with Preserved or Reduced Ejection Fraction.
Autorzy:
Hirose S; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Miyazaki S; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Yatsu S; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Sato A; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Ochanomizu KS building #303, 3-3-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Ishiwata S; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Ochanomizu KS building #303, 3-3-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Matsumoto H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Shitara J; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Murata A; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Kato T; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Suda S; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Matsue Y; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Ochanomizu KS building #303, 3-3-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Hiki M; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Takagi A; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Daida H; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Kasai T; Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.; Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Ochanomizu KS building #303, 3-3-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.; Cardiovascular Management and Remote Monitoring, Juntendo University Graduate School of Medicine, Ochanomizu KS building #303, 3-3-1, Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2020 Apr 19; Vol. 9 (4). Date of Electronic Publication: 2020 Apr 19.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people
Autorzy:
Kinoshita K; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Toshikuni N; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Saito T; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Hayashi N; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Minato T; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Matsue Y; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Ueda Y; Department of Pathology II, Kanazawa Medical University, Ishikawa, Japan
Tsuchishima M; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Tsutsumi M; Department of Hepatology, Kanazawa Medical University, Ishikawa, Japan
Pokaż więcej
Źródło:
Turkish journal of medical sciences [Turk J Med Sci] 2019 Oct 24; Vol. 49 (5), pp. 1350-1357. Date of Electronic Publication: 2019 Oct 24.
Typ publikacji:
Journal Article
MeSH Terms:
Fatty Liver/*complications
Plaque, Atherosclerotic/*etiology
gamma-Glutamyltransferase/*blood
Aged ; Carotid Stenosis/blood ; Carotid Stenosis/epidemiology ; Carotid Stenosis/etiology ; Female ; Humans ; Incidence ; Male ; Plaque, Atherosclerotic/blood ; Plaque, Atherosclerotic/epidemiology ; Proportional Hazards Models ; Risk Factors ; Time Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The time-to-treatment concept in acute heart failure: Lessons and implications from REALITY-AHF.
Autorzy:
Kagiyama N
Matsue Y; Department of Cardiovascular Medicine, Juntendo University School of Medicine; Tokyo-Japan. .
Pokaż więcej
Źródło:
Anatolian journal of cardiology [Anatol J Cardiol] 2018 Aug; Vol. 20 (2), pp. 125-129.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Time-to-Treatment*
Heart Failure/*therapy
Humans ; Prospective Studies ; Registries
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
Autorzy:
Emmens JE; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Ter Maaten JM; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Matsue Y; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Metra M; University of Brescia, Brescia, Italy.
O'Connor CM; Duke University Medical Center, Durham, NC, USA.
Ponikowski P; Medical University, Clinical Military Hospital, Wroclaw, Poland.
Teerlink JR; University of California at San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.
Cotter G; Momentum Research, Durham, NC, USA.
Davison B; Momentum Research, Durham, NC, USA.
Cleland JG; University of Hull, Kingston upon Hull, UK.
Givertz MM; Brigham and Women's Hospital, Boston, MA, USA.
Bloomfield DM; Merck Research Laboratories, Rahway, NJ, USA.
Dittrich HC; University of Iowa Carver College of Medicine Cardiovascular Research Center, Iowa City, IA, USA.
Todd J; Singulex Inc., Alameda, CA, USA.
van Veldhuisen DJ; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Hillege HL; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, The Netherlands.
Damman K; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
van der Meer P; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Voors AA; University of Groningen, University Medical Center Groningen, Department of Cardiology, Groningen, The Netherlands.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2016 Jun; Vol. 18 (6), pp. 641-9. Date of Electronic Publication: 2015 Oct 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Glomerular Filtration Rate*
Renal Circulation*
Creatinine/*blood
Cystatin C/*blood
Heart Failure/*blood
Hepatitis A Virus Cellular Receptor 1/*blood
Natriuretic Peptide, Brain/*blood
Peptide Fragments/*blood
Serum Albumin/*metabolism
Acetylglucosaminidase/urine ; Acute Disease ; Adult ; Aged ; Chronic Disease ; Female ; Hepatitis A Virus Cellular Receptor 1/metabolism ; Humans ; Kidney Tubules/metabolism ; Lipocalin-2/urine ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clinical features and treatment outcome of very elderly patients over 80 years old with multiple myeloma: comparison with patients in different age groups in the era of novel agents.
Autorzy:
Matsue K; a Division of Hematology/Oncology, Department of Medicine , Kameda Medical Center , Kamogawa-shi , Japan.
Matsue Y; b Department of Cardiology , University Medical Center Groninge , Groninge , The Netherlands.
Fujisawa M; a Division of Hematology/Oncology, Department of Medicine , Kameda Medical Center , Kamogawa-shi , Japan.
Fukumoto K; a Division of Hematology/Oncology, Department of Medicine , Kameda Medical Center , Kamogawa-shi , Japan.
Suehara Y; a Division of Hematology/Oncology, Department of Medicine , Kameda Medical Center , Kamogawa-shi , Japan.
Sugihara H; a Division of Hematology/Oncology, Department of Medicine , Kameda Medical Center , Kamogawa-shi , Japan.
Takeuchi M; a Division of Hematology/Oncology, Department of Medicine , Kameda Medical Center , Kamogawa-shi , Japan.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (1), pp. 110-5. Date of Electronic Publication: 2015 Jul 07.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*diagnosis
Multiple Myeloma/*drug therapy
Age Factors ; Aged ; Aged, 80 and over ; Biomarkers ; Chromosome Aberrations ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Multiple Myeloma/mortality ; Prognosis ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 26

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies